H. Al‐Abadi

510 total citations
24 papers, 326 citations indexed

About

H. Al‐Abadi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, H. Al‐Abadi has authored 24 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in H. Al‐Abadi's work include Prostate Cancer Treatment and Research (7 papers), Renal cell carcinoma treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). H. Al‐Abadi is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Renal cell carcinoma treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). H. Al‐Abadi collaborates with scholars based in Germany, United States and France. H. Al‐Abadi's co-authors include R. Nagel, Hassan Abou‐Rebyeh, Bertram Wiedenmann, Martin Koch, Ioannis S. Papanikolaou, M. Schmidt‐Gollwitzer, Thomas Rösch, T Toermer, Mario Sarbia and Harald Schmidt and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

H. Al‐Abadi

23 papers receiving 310 citations

Peers

H. Al‐Abadi

SURGE

PRM

ONCOL

EPIDE

HEPAT

Jennifer A. Shannon Australia

Zhong-Guo Zhou China

Paula Abreu-e-Lima United States

Yoriko Takezako Japan

G.F. Samelis Greece

Quan Bao China

C Partensky France

A. Millà Spain

R. Doerr United States

Fernanda Menozzi Italy

Jennifer A. Shannon Australia

H. Al‐Abadi

119 ×0.8

SURGE

124 ×0.9

PRM

150 ×1.1

ONCOL

43 ×0.7

EPIDE

196 ×3.2

HEPAT

Citations per year, relative to H. Al‐Abadi H. Al‐Abadi (= 1×) peers Jennifer A. Shannon

Countries citing papers authored by H. Al‐Abadi

Since Specialization

Citations

This map shows the geographic impact of H. Al‐Abadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Al‐Abadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Al‐Abadi more than expected).

Fields of papers citing papers by H. Al‐Abadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Al‐Abadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Al‐Abadi. The network helps show where H. Al‐Abadi may publish in the future.

Co-authorship network of co-authors of H. Al‐Abadi

This figure shows the co-authorship network connecting the top 25 collaborators of H. Al‐Abadi. A scholar is included among the top collaborators of H. Al‐Abadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Al‐Abadi. H. Al‐Abadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Möller, Kathleen, Ioannis S. Papanikolaou, T Toermer, et al.. (2009). EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointestinal Endoscopy. 70(1). 60–69. 88 indexed citations

Papanikolaou, Ioannis S., Andreas Adler, H. Al‐Abadi, et al.. (2008). Prospective pilot evaluation of a new needle prototype for endoscopic ultrasonography-guided fine-needle aspiration: comparison of cytology and histology yield. European Journal of Gastroenterology & Hepatology. 20(4). 342–348. 14 indexed citations

Ricke, Jens, Max Seidensticker, Lutz Lüdemann, et al.. (2005). In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. International Journal of Radiation Oncology*Biology*Physics. 62(3). 776–784. 42 indexed citations

Abou‐Rebyeh, Hassan, et al.. (2002). DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance. Cancer Detection and Prevention. 26(4). 313–319. 8 indexed citations

Abou‐Rebyeh, Hassan, et al.. (2001). DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma. Cancer. 92(9). 2280–2285. 23 indexed citations

Neuhaus, P., Sven Jonas, Wolf O. Bechstein, et al.. (1999). Liver transplantation for hepatocellular carcinoma. Transplantation Proceedings. 31(1-2). 469–471. 23 indexed citations

Al‐Abadi, H., R. Nagel, & P. Neuhaus. (1998). Immunohistochemical Detection of p53 Protein in Transitional Cell Carcinoma of the Bladder in Correlation to DNA Ploidy and Pathohistological Stage and Grade. Cancer Detection and Prevention. 22(1). 43–50. 4 indexed citations

Al‐Abadi, H.. (1997). Fine Needle Aspiration Biopsy vs. Ultrasound-Guided Transrectal Random Core Biopsy of the Prostate. Acta Cytologica. 41(4). 981–986. 5 indexed citations

Al‐Abadi, H. & R. Nagel. (1994). Deoxyribonucleic Acid Content and Survival Rates of Patients with Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 151(1). 37–42. 16 indexed citations

10.

Al‐Abadi, H., et al.. (1993). Effect of Different Local and Systemic Therapy upon Urinary Bladder Cytology. Urologia Internationalis. 50(1). 21–26. 3 indexed citations

11.

Al‐Abadi, H. & R. Nagel. (1992). Transitional Cell Carcinoma of the Renal Pelvis and Ureter: Prognostic Relevance of Nuclear Deoxyribonucleic Acid Ploidy Studied by Slide Cytometry: An 8-Year Survival Time Study. The Journal of Urology. 148(1). 31–37. 21 indexed citations

12.

Al‐Abadi, H., et al.. (1991). The Prognostic Significance of Ploidy and DNA-Heterogeneity in the Primary Diagnosis and Monitoring of Patients with Locally Advanced Prostatic Carcinoma. Scandinavian Journal of Urology and Nephrology. 25(sup138). 83–92. 9 indexed citations

13.

Al‐Abadi, H., et al.. (1991). Prognostic Relevance of DNA Ploidy and Proliferative Activity in Urothelial Carcinoma of the Renal Pelvis and Ureter. Urologia Internationalis. 47(1). 7–11. 2 indexed citations

14.

Al‐Abadi, H. & R. Nagel. (1990). Nuclear DNA Analysis: The Relevance of Ploidy, DNA Heterogeneity and Phases of the Cell Cycle in 329 Patients with Prostatic Carcinoma. Urologia Internationalis. 45(6). 350–355. 13 indexed citations

15.

Al‐Abadi, H. & R. Nagel. (1988). Prognostic Relevance of Ploidy and Proliferative Activity ofRenal Cell Carcinoma. European Urology. 15(3-4). 271–276. 9 indexed citations

16.

Al‐Abadi, H., et al.. (1988). Treatment of Locally Advanced Prostatic Carcinoma With LHRH Analogues. American Journal of Clinical Oncology. 11(Supplement 1). S29–S29. 7 indexed citations

17.

Nagel, R., et al.. (1983). [1st clinical results of the treatment of locally advanced prostatic cancer with a powerful LH-RH analog: buserelin acetate].. PubMed. 89(9). 669–76. 1 indexed citations

18.

Nagel, R., et al.. (1983). Treatment of prostatic cancer with LH‐RH analogues. The Prostate. 4(6). 553–568. 29 indexed citations

19.

Al‐Abadi, H., et al.. (1976). Depression der Disaccharidaseaktivit�ten unter Bencyclan-Hydrogenfumarat. Journal of Molecular Medicine. 54(18). 895–897. 1 indexed citations

20.

Al‐Abadi, H., et al.. (1975). [Morphometric studies on gastric border cells in rats during chronic alcohol administration].. PubMed. 59. 586–586. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact